Home / Research library / Tesofensine Capsules
Tesofensine Capsules: molecular data, studies & sources
Tesofensine Capsules is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C17H23Cl2NO
- Molecular weight (MW)
- 328.3 g/mol
- PubChem compound ID
- 11370864
- Record title
- Tesofensine
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 11370864 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
- InChIKey
- VCVWXKKWDOJNIT-ZOMKSWQUSA-N
- SMILES
- CCOC[C@H]1[C@H]2CC[C@H](N2C)C[C@@H]1C3=CC(=C(C=C3)Cl)Cl
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
Schoedel KA, Meier D, Chakraborty B et al. · Clinical pharmacology and therapeutics · 2010
PMID 20520602 · DOI: 10.1038/clpt.2010.67
- Human study · PubMed trial index
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
Astrup A, Madsbad S, Breum L et al. · Lancet (London, England) · 2008
PMID 18950853 · DOI: 10.1016/S0140-6736(08)61525-1
- Human study · PubMed trial index
[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].
Nielsen AL, Larsen TM, Madsbad S et al. · Ugeskrift for laeger · 2009
PMID 19824222
- Human study · PubMed trial index
Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
Rascol O, Poewe W, Lees A et al. · Archives of neurology · 2008
PMID 18474731 · DOI: 10.1001/archneur.65.5.577
- Human study · PubMed trial index
A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.
Lehr T, Staab A, Tillmann C et al. · Clinical pharmacokinetics · 2009
PMID 19705923 · DOI: 10.2165/11313370-000000000-00000
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity.
Bello NT, Zahner MR · Current opinion in investigational drugs (London, England : 2000) · 2009
PMID 19777399
- Preclinical / laboratory research
Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons.
Perez CI, Luis-Islas J, Lopez A et al. · PloS one · 2024
PMID 38656972 · DOI: 10.1371/journal.pone.0300544
Tesofensine Capsules supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all Tesofensine Capsules sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 500mcg×30 Capsules1 recorded offers | 500mcg×30 Capsules · $112.49Checked Sep 16, 2026Supplier listing |
| Cenexa LabsUSD | 500mcg×60 Capsules1 recorded offers | 500mcg×60 Capsules · $136.99Checked Sep 16, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 11370864 — chemical identity and structure.
- Wikipedia: Tesofensine — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
ACE-031
Molecular identity needs further verification
4 selected publications · 2 human study records
Adipotide
C111H206N36O28S2
2557.2 g/mol · PubChem CID 163360068
0 selected publications · 0 human study records
AICAR
C9H14N4O5
258.23 g/mol · PubChem CID 17513
4 selected publications · 3 human study records
Dermorphin
C40H50N8O10
802.9 g/mol · PubChem CID 5485199
1 selected publications · 1 human study records
Enclomiphene
C26H28ClNO
406.0 g/mol · PubChem CID 1548953
5 selected publications · 3 human study records
Follistatin 344
Molecular identity needs further verification
4 selected publications · 0 human study records